# Neuphoria Therapeutics Inc. (NEUP)

> Source: Nexqual · https://nexqual.com/NEUP · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Neuphoria Therapeutics Inc. (NEUP), nexqual.com/NEUP" · informational, not investment advice.

**Price:** USD 3.31 (+2.16% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 3.24 · day 3.25–3.42 · 52w 3.19–17.19 · market cap $17.9M · NGM

## Key facts
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts).
- Total return with dividends: 1Y -78.2% vs S&P 500 +18.1%; 5Y -97.9% vs S&P 500 +85.1%.

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-12-13) |
|---|---|---|
| Total return | -78.2% | -97.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -78.3% | -54.9% |
| Volatility (annualized) | 139.6% | 119.7% |
| Max drawdown | -79.1% (Oct 2025→Oct 2026) | -98.5% (Dec 2021→Oct 2024) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/NEUP · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt